This opportunity is no longer accepting applications.
grant RFA-DA-25-057

Combined Neuromodulation and Behavioral Treatment Algorithm Development for Stimulant Use Disorder (StUD) Enriched for Vulnerable Phenotype (U01 Clinical Trial Required)

The grant opportunity focuses on developing treatments for Stimulant Use Disorder (StUD) using neuromodulation techniques, like transcranial magnetic stimulation (TMC) and transcranial direct current stimulation (tDCS), which have been effective in treating other mental health disorders. Since many StUD patients don't respond uniformly to treatments due to variability in traits like cognitive …

Stimulant Use Disorder still does not have FDA- approved treatments. Neuromodulation, such as, for example, transcranial magnetic stimulation (TMC) has been successfully used for more than 10 years in major depressive disorder (MDD) where patients have failed one antidepressant and since 2018 it…

Funding Source

Agency: National Institutes of Health
Sub-agency: National Institute on Drug Abuse
Program: SBIR

Awards & funding

Award Ceiling: $500,000
Award Amount: $500,000

Dates

Submission Deadline: November 27, 2024
Application Window Closes: November 27, 2024
Opportunity Released: June 27, 2024
Open for Submission: June 27, 2024

Supporting links

Secure Grant Funding 10x Faster

Scout delivers AI-powered grant writing paired with experts that's faster, more affordable, and built to win.

Already have an account? Sign In

Trusted by 500+ Happy Customers

Get opportunities sent to your inbox

The latest grant news and insights from our experts.

Save this opportunity and explore more

Share Opportunity

Share this opportunity with others.
Anyone with this link can view the opportunity details.